Preparation of Sesquiterpene Lactone Derivatives: Cytotoxic Activity and Selectivity of Action

Cancer is one of the most important causes of death worldwide. Solid tumors represent the great majority of cancers (>90%) and the chemotherapeutic agents used for their treatment are still characterized by variable efficacy and toxicity. Sesquiterpene lactones are a group of naturally occurring...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Molecules (Basel, Switzerland) Switzerland), 2019-03, Vol.24 (6), p.1113
Hauptverfasser: Beer, María F, Bivona, Augusto E, Sánchez Alberti, Andrés, Cerny, Natacha, Reta, Guillermo F, Martín, Víctor S, Padrón, José M, Malchiodi, Emilio L, Sülsen, Valeria P, Donadel, Osvaldo J
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Cancer is one of the most important causes of death worldwide. Solid tumors represent the great majority of cancers (>90%) and the chemotherapeutic agents used for their treatment are still characterized by variable efficacy and toxicity. Sesquiterpene lactones are a group of naturally occurring compounds that have displayed a diverse range of biological activities including cytotoxic activity. A series of oxygenated and oxy-nitrogenated derivatives ( ⁻ ) from the sesquiterpene lactones cumanin ( ), helenalin ( ), and hymenin ( ) were synthesized. The silylated derivatives of helenalin, compounds and , were found to be the most active against tumor cell lines, with GI values ranging from 0.15 to 0.59 μM. The ditriazolyl cumanin derivative ( ) proved to be more active and selective than cumanin in the tested breast, cervix, lung, and colon tumor cell lines. This compound was the least toxic against splenocytes (CC = 524.1 µM) and exhibited the greatest selectivity on tumor cell lines. This compound showed a GI of 2.3 µM and a SI of 227.9 on WiDr human colon tumor cell lines. Thus, compound can be considered for further studies and is a candidate for the development of new antitumor agents.
ISSN:1420-3049
1420-3049
DOI:10.3390/molecules24061113